指南与共识甲状腺与浅表介入US

超声引导热消融治疗T1b及部分T2甲状腺乳头状癌:证据、指南推荐与超声工作流程

Ultrasound-guided thermal ablation for T1b and selected T2 papillary thyroid carcinoma: current evidence, evolving guideline recommendations, and an ultrasound-based clinical workflow.
指南 / 共识 · Ultrasonography · 2026-10-27

本文综述了热消融治疗T1b及部分T2甲状腺乳头状癌的现有证据与指南推荐。T1b研究显示局部控制令人鼓舞且永久性并发症率低,但证据为回顾性、地域集中且异质,手术仍是参考治疗。四项回顾性T2报告提示手术安全边际更窄;随肿瘤增大,符合肿瘤学和技术要求的患者减少,分期或切缘不完整的后果更严重。

要点

  • T1b甲状腺乳头状癌热消融证据以回顾性研究为主,局部控制好、永久并发症少,但手术仍是参考治疗。
  • T2甲状腺乳头状癌热消融安全边际更窄,仅四项回顾性报告,需更严格选择患者。
  • T1a、T1b、T2采用相同解剖选择标准,但肿瘤越大,符合条件者越少,分期或切缘不完整的后果越重。

诊断标准与关键数值

  • T1a、T1b和T2甲状腺乳头状癌采用相同的解剖选择标准,但肿瘤增大时符合肿瘤学和技术要求的患者减少。

临床应用与阅片要点

  • 对T1b及部分T2甲状腺乳头状癌考虑热消融时,应严格评估解剖选择标准并充分告知手术仍是参考治疗。
  • 肿瘤越大,越需警惕分期或切缘不完整带来的严重后果,审慎选择患者。

局限性

  • T1b证据为回顾性、地域集中且异质,T2仅有四项回顾性报告,整体证据等级有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Thermal ablation (TA) is established for benign thyroid nodules, recurrent thyroid carcinoma, and low-risk papillary thyroid microcarcinoma. Its role in papillary thyroid carcinoma (PTC) remains unsettled. This review examines evidence and guideline recommendations for TA in T1b and selected T2 PTC. T1b studies suggest encouraging local control and low permanent morbidity, but retrospective, geographically concentrated, heterogeneous evidence leaves surgery as the reference treatment. Four retrospective T2 reports indicate a narrower procedural safety margin. The same anatomical selection criteria apply across T1a, T1b, and T2 disease; however, as tumors enlarge, fewer patients meet oncological and technical requirements, and incomplete staging or margins have greater consequences.

来源:Ultrasonography,查看原文。版权归原作者所有。

引用

  1. Lu CY, Wang CK, Chang-Chien GP, et al. Ultrasound-guided thermal ablation for T1b and selected T2 papillary thyroid carcinoma: current evidence, evolving guideline recommendations, and an ultrasound-based clinical workflow. Ultrasonography. 2026. PMID: 42958856. doi:10.14366/usg.26199

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。